PEP-Therapy and Institut Curie Announce First Patients Dosed in Phase Ib Clinical Trial Evaluating PEP-010 in Ovarian and Pancreatic Cancers
GlobeNewswire
Press release
*PEP-Therapy and Institut Curie Announce First Patients Dosed*
*in Phase Ib Clinical Trial Evaluating..
![L'origine génétique des Québécois [EN DIRECT]](https://video.newsserve.net/300/v/20230613/1686640243-apos-origine-génétique-des-Québécois-EN-DIRECT.jpg)